Market HighlightsTaste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report.
Avail the in-depth table of content (TOC) & market synopsis on “Creatinine Test Market research report–Global forecast till 2023.”Creatinine test is a part of renal function tests that determine the normal functioning of kidney.
Furthermore, increasing research and development activities, and technological advancements to identify the causes and risk factors for renal diseases are fuelling the global market growth.
The growth of the market is restricted by the accuracy and reliability of tests.The global creatinine test market is expected to grow at a CAGR of 4.2% during the forecast period.Some of the key players in the global market are Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia), Bayer (U.S.), Beckman Coulter (U.S.), Laboratory Corporation of America Holdings (U.S.), Genoptix (U.S.), Healthscope (Australia), Labco (Kuwait), Charles River (U.S.), OPKO Health, Inc. (U.S.), Abbott (U.S.), and others.Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4878Major Players in Creatinine test Market:Regional AnalysisThe creatinine test market is increasing in the Americas owing to growing emphasis on healthy lifestyle, and prevention of chronic kidney diseases.
Additionally, increasing demand for technologically advanced diagnostic devices and the presence of major market players influence the growth of the market.
According to the Centre for Disease Control and Prevention, in 2014, nearly 118,000 people in the U.S. started treatment for End-Stage Renal Disease (ESRD).In Europe, extensive research and development activities on the medical devices, and extensive use of point-care-testing devices drive the market growth.